Literature DB >> 9055520

Case study: two additional sudden deaths with tricyclic antidepressants.

C K Varley1, J McClellan.   

Abstract

Since 1990, there have been five reported cases of sudden death in children treated with desipramine. This case study describes the sudden deaths of two additional children treated with tricyclic antidepressants, one with desipramine, 3.3 mg/kg per day, the other with imipramine, 6 mg/kg per day and thioridazine, 1 mg/kg per day. The reports add to concerns about the use of tricyclics in children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9055520     DOI: 10.1097/00004583-199703000-00018

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  13 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 2.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 3.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

Review 4.  Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.

Authors:  Mark L Wolraich; Laura McGuinn; Melissa Doffing
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.

Authors:  C K Varley
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  School refusal: epidemiology and management.

Authors:  D Heyne; N J King; B J Tonge; H Cooper
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder.

Authors:  M Cyr; C S Brown
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 8.  Comparative tolerability of drug treatment for nocturnal enuresis in children.

Authors:  Dominik Müller; Charles C Roehr; Paul Eggert
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.

Authors:  Andrew R. Adesman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 10.  Tricyclic drugs for depression in children and adolescents.

Authors:  Philip Hazell; Mohsen Mirzaie
Journal:  Cochrane Database Syst Rev       Date:  2013-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.